Regulatory News
Friday, December 16, 2016
BRIEF-TG Therapeutics says mid-stage data published in the British Journal of Haematology
* TG Therapeutics Inc announces publication of clinical data
from the phase 2 trial of TG-1101 (ublituximab) in combination
with ibrutinib in the british journal of haematology
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment